Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Dividend Yield % : 0.33% (As of Apr. 29, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Clinuvel Pharmaceuticals Dividend Yield %?

As of today (2024-04-29), the Trailing Annual Dividend Yield of Clinuvel Pharmaceuticals is 0.33%.

Good Sign:

Clinuvel Pharmaceuticals Ltd stock dividend yield is close to 5-year high.

The historical rank and industry rank for Clinuvel Pharmaceuticals's Dividend Yield % or its related term are showing as below:

CLVLF' s Dividend Yield % Range Over the Past 10 Years
Min: 0.05 Med: 0.11 Max: 0.33
Current: 0.33

During the past 13 years, the highest Dividend Yield of Clinuvel Pharmaceuticals was 0.33%. The lowest was 0.05%. And the median was 0.11%.

CLVLF's Dividend Yield % is ranked worse than
88% of 150 companies
in the Biotechnology industry
Industry Median: 1.495 vs CLVLF: 0.33

Clinuvel Pharmaceuticals's Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.23.

During the past 13 years, the highest Dividend Payout Ratio of Clinuvel Pharmaceuticals was 0.09. The lowest was 0.05. And the median was 0.06.

As of today (2024-04-29), the Forward Dividend Yield % of Clinuvel Pharmaceuticals is 0.33%.

Clinuvel Pharmaceuticals's Dividends per Share for the six months ended in Dec. 2023 was $0.03.

During the past 12 months, Clinuvel Pharmaceuticals's average Dividends Per Share Growth Rate was 25.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 17.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Clinuvel Pharmaceuticals was 17.00% per year. The lowest was 7.70% per year. And the median was 12.35% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Clinuvel Pharmaceuticals Dividend Yield % Historical Data

The historical data trend for Clinuvel Pharmaceuticals's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinuvel Pharmaceuticals Dividend Yield % Chart

Clinuvel Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Dividend Yield %

Get a 7-Day Free Trial

0.09

0.19

0.22

Clinuvel Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Dividend Yield %	Get a 7-Day Free Trial															0.09	0.19	0.19	0.22	0.31

Competitive Comparison of Clinuvel Pharmaceuticals's Dividend Yield %

For the Biotechnology subindustry, Clinuvel Pharmaceuticals's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clinuvel Pharmaceuticals's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clinuvel Pharmaceuticals's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Clinuvel Pharmaceuticals's Dividend Yield % falls into.

Clinuvel Pharmaceuticals Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Clinuvel Pharmaceuticals Recent Full-Year* Dividend History

Amount	Ex-date	Record Date	Pay Date	Type	Frequency	Forex Rate
AUD 0.050	2023-09-05	2023-09-06	2023-09-20	Cash Dividend	annually	AUD:USD 0.648508

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Clinuvel Pharmaceuticals's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield	=	Most Recent Full Year Dividend	/	Current Share Price
	=	0.0324254	/	9.82
	=	0.33 %

Current Share Price is $9.82.
Clinuvel Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.0324254.

Clinuvel Pharmaceuticals's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield	=	Forward Full Year Dividend	/	Current Share Price
	=	0.0324254	/	9.82
	=	0.33 %

Current Share Price is $9.82.
Clinuvel Pharmaceuticals's Dividends per Share for the forward twelve months is calculated as $0.0324254 * 1 = $0.0324254.

Clinuvel Pharmaceuticals (OTCPK:CLVLF) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Clinuvel Pharmaceuticals Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Clinuvel Pharmaceuticals's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clinuvel Pharmaceuticals (Clinuvel Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (OTCPK:CLVLF) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

CLVLY:USA UR9:Germany CUV:Australia

Address

535 Bourke Street, Level 11, Melbourne, VIC, AUS, 3000

Website

https://www.clinuvel.com

Clinuvel distributes a single-product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the U.S.